Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication for migraine prevention.
Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication for migraine prevention.
Migraines are a neurological condition that can cause throbbing or pulsating head pain and may be accompanied by symptoms such as nausea, vomiting, sensitivity to light, sensitivity to sound, or aura. For some people, migraine attacks continue even after trying preventive treatment options.
You may be able to join if you:
-Are 18 to 70 years of age
-Have been living with migraine for at least 1 year
-Started having migraine attacks at age 50 or younger
-Have several migraine days each month
-Have tried at least 2 different prescription migraine prevention treatments that did not work well enough for you
-Can tell the difference between your migraine headaches and other types of headaches
Adults with osteoarthritis (OA) knee pain may qualify for a research study evaluating an investigational medication for chronic pain relief.
Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.
Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication […]
Adults 18 to younger than 65 years of age living with overweight or obesity may qualify for a clinical research […]
A vaccine research study is expected to open for enrollment in the coming weeks. Join our notification list to be […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]